T-cell Immunogenicity
T-Cell Immunogenicity is the capacity of a recombinant protein vaccine to elicit a specific adaptive immune response mediated by T lymphocytes through the activation and proliferation of CD4+ and/or CD8+ T cells against target antigens.
1K
Publications
65.5K
Citations
8.3K
Authors
1.7K
Institutions
Publications per year
2017–2026
287
Parents
1K
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
Uğur Şahin, Alexander Muik, Isabel Vogler et al. · Nature · 2021 · 833 citations · Full text
Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4
Paul T. Golumbek, Audrey J. Lazenby, Hyam I. Levitsky et al. · Science · 1991 · 731 citations
Medicine, Immunology, Oncology +17
Jörg Schneider, Sarah C. Gilbert, Tom Blanchard et al. · Nature Medicine · 1998 · 649 citations
1–5 of 1K
8.3K
24
h-index
20
h-index
15
h-index
15
h-index
10
h-index
1–5 of 8.3K
1.7K
National Institutes of Health
Bethesda, United States
36 h-index
256 publications
24.9K citations
University of Oxford
Oxford, United Kingdom
36 h-index
739 publications
240.3K citations
National Institute of Allergy and Infectious Diseases
Bethesda, United States
29 h-index
152 publications
21.3K citations
Harvard University
Cambridge, United States
24 h-index
133 publications
7.8K citations
University of Washington
Seattle, United States
24 h-index
129 publications
11.6K citations
Inserm
Paris, France
22 h-index
182 publications
10.8K citations
National Cancer Institute
Bethesda, United States
21 h-index
127 publications
6.4K citations
Jenner Institute
Oxford, United Kingdom
20 h-index
251 publications
76.9K citations
1–8 of 1.7K
116 publications · 5.3K citations
43
h-index
JI · 71 publications · 5.4K citations
41
h-index
PNAS · 29 publications · 4.7K citations
29
h-index
JVI · 44 publications · 2.6K citations
29
h-index
JID · 28 publications · 2.1K citations
24
h-index
1–5